ANACOR PHARMACT (ANAC)
(Delayed Data from NSDQ)
$99.20 USD
+0.03 (0.03%)
Updated Jun 23, 2016 04:00 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[ANAC]
Reports for Purchase
Showing records 1 - 20 ( 312 total )
Industry: Medical - Drugs
Industry: Medical - Drugs
Recent Drug Launch Weekly Retail Sales Tracker- Week Ended June 17
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Drugs
Industry: Medical - Drugs
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended May 20
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Drugs
Anacor and Sandoz''s KERYDIN (tavaborole): Weekly Retail Sales Estimates
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Drugs
Industry: Medical - Drugs
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended May 13
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Drugs
Downgrading to NEUTRAL; Pfizer to Buy ANAC for $99.25/sh, Other Counter-Bids or Higher bid Price Unlikely
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Drugs
Industry: Medical - Drugs
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended May 6
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Drugs
1Q, Our Investment Thesis Remains Intact Despite Kerydin Sales Slowdown, Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Drugs
Industry: Medical - Drugs
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended April 29
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Drugs
1Q Preview; Trimming PT to $148 on Tougher Pricing Environment for Kerydin, but Reiterating OP Rating as Crisaborole Value Remains Underappreciated
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Drugs
Industry: Medical - Drugs
Recent Drug Launch Weekly Retail Sales Tracker
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Drugs
Industry: Medical - Drugs
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended April 15
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Drugs
Industry: Medical - Drugs
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended April 8
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D